Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
Glutathione Supports Cardiovascular Health One of glutathiones benefits for athletes is especially vital in regard to heart health
Is getting a vitamin B12 booster shot worth it, even if I am not B12 deficient
The major players in the obesity GLP-1 market include Novo Nordisk A/S, Eli Lilly and Company, Amgen, Viking Therapeutic, AstraZeneca, Roche (Carmot Therapeutics), Boehringer Ingelheim, Pfizer Inc., Altimmune, Inc., and Structure Therapeutics
An NPR report from February 2026 explored the benefits and risks of using GLP-1 medications at a normal BMI, noting that the long-term effects of these drugs in normal-weight populations are not well studied
Diabetologia 67 , 483493 (2024)
US$ 20.07
US$ 20.49
US$ 23.84
